Peptidomimetic inhibitors of renin incorporating topographically modified isosteres spanning the P1(→ P3)-P1' sites
暂无分享，去创建一个
[1] P. Kovar,et al. Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy. , 1992, Science.
[2] A. Doherty,et al. Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors. , 1992, Journal of medicinal chemistry.
[3] C. Humblet,et al. Renin inhibitors containing esters at the P2-position. Oral activity in a derivative of methyl aminomalonate. , 1991, Journal of medicinal chemistry.
[4] N. Peet,et al. An efficient synthesis of novel .alpha.-diketone and .alpha.-keto ester derivatives of N-protected amino acids and peptides , 1989 .
[5] D. Egan,et al. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency. , 1988, Journal of medicinal chemistry.
[6] J. Greer,et al. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site. , 1988, Journal of medicinal chemistry.
[7] T. Lin,et al. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine. , 1985, Journal of medicinal chemistry.
[8] W. Christ,et al. On stereochemistry of osmium tetraoxide oxidation of allylic alcohol systems. Empirical rule , 1983 .
[9] S. Nahm,et al. N-methoxy-n-methylamides as effective acylating agents , 1982 .